XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.2
EARNINGS PER SHARE
 6 Months Ended
Jun. 29, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The following table reconciles net (loss) earnings and the weighted-average shares outstanding used to calculate basic and diluted (loss) earnings per share of common stock for the three and six months ended June 29, 2024 and July 1, 2023:
Second QuarterYear-to-Date
2024202320242023
Numerator (in millions):
Net (loss) earnings from continuing operations $(19.2)$177.5 $0.3 $(10.3)
Net earnings (loss) from discontinued operations8.0 (0.5)8.0 (0.5)
Net (Loss) Earnings$(11.2)$177.0 $8.3 $(10.8)

Second QuarterYear-to-Date
2024202320242023
Denominator (in thousands):
Basic weighted-average shares outstanding150,394 149,687 150,311 149,631 
Dilutive effect of stock contracts and awards— 540 701 — 
Diluted weighted-average shares outstanding150,394 150,227 151,012 149,631 

Second QuarterYear-to-Date
2024202320242023
(Loss) earnings per share of common stock:
Basic (loss) earnings per share of common stock:
Continuing operations$(0.13)$1.19 $— $(0.07)
Discontinued operations$0.05 $— $0.05 $— 
Total basic (loss) earnings per share of common stock$(0.07)$1.18 $0.06 $(0.07)
Diluted (loss) earnings per share of common stock:
Continuing operations$(0.13)$1.18 $— $(0.07)
Discontinued operations$0.05 $— $0.05 $— 
Total diluted (loss) earnings per share of common stock$(0.07)$1.18 $0.05 $(0.07)


The following weighted-average stock options were not included in the computation of weighted-average diluted shares outstanding because the effect would be anti-dilutive (in thousands):
Second QuarterYear-to-Date
2024202320242023
Number of stock options5,739 5,857 5,367 5,796 
In March 2015, the Company entered into a forward share purchase contract with a financial institution counterparty for 3,645,510 shares of common stock. The contract obligates the Company to pay $350.0 million, plus an additional amount related to the forward component of the contract. In June 2024, the Company amended the settlement date to June 2026, or earlier at the Company's option. The reduction of common shares outstanding was recorded at the inception of the forward share purchase contract in March 2015 and factored into the calculation of weighted-average shares outstanding at that time.